Recombinant Human Granulocyte Colony-Stimulating Market Report

China Recombinant Human Granulocyte Colony-Stimulating Industry Market Research Report 2023-2029

  • POSTDATE：Sep 15, 2023
  • PAGES：186
  • REPORT CODE：GMM1798562
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Recombinant Human Granulocyte Colony-Stimulating industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Huaxin

    • Shijiazhuang Pharmaceutical

    • Qilu Pharmaceutical

    • Zhaoke

    • Amoytop Biotech

    • Triprime

    • Amgen

    • Sinovac

    • Kawin

    • Gensci

    By Type:

    • Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

    • Lenograstim (Granocyte)

    • Others

    By Application:

    • Chemotherapy Induced Neutropenia

    • Stem Cell Transplants

    • Before Blood Donation

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Recombinant Human Granulocyte Colony-Stimulating Market Overview 2018-2029

    • 1.1 China Recombinant Human Granulocyte Colony-Stimulating Industry Development Overview

    • 1.2 China Recombinant Human Granulocyte Colony-Stimulating Industry Development History

    • 1.3 China Recombinant Human Granulocyte Colony-Stimulating Industry Market Size (2018-2029)

    • 1.4 China Recombinant Human Granulocyte Colony-Stimulating Market Analysis by Type from Production Side

      • 1.4.1 China Recombinant Human Granulocyte Colony-Stimulating Production Volume, Production Value and Growth Rate of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) (2018-2029)

      • 1.4.2 China Recombinant Human Granulocyte Colony-Stimulating Production Volume, Production Value and Growth Rate of Lenograstim (Granocyte) (2018-2029)

      • 1.4.3 China Recombinant Human Granulocyte Colony-Stimulating Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Recombinant Human Granulocyte Colony-Stimulating Market Analysis by Application from Consumption End

      • 1.5.1 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate of Chemotherapy Induced Neutropenia (2018-2029)

      • 1.5.2 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate of Stem Cell Transplants (2018-2029)

      • 1.5.3 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate of Before Blood Donation (2018-2029)

      • 1.5.4 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Recombinant Human Granulocyte Colony-Stimulating Market Analysis by Region

      • 1.6.1 North China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

    Chapter 2 China Recombinant Human Granulocyte Colony-Stimulating Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Recombinant Human Granulocyte Colony-Stimulating Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Recombinant Human Granulocyte Colony-Stimulating Market Status and Competition Analysis in 2023

      • 2.2.3 China Recombinant Human Granulocyte Colony-Stimulating Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Recombinant Human Granulocyte Colony-Stimulating Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Recombinant Human Granulocyte Colony-Stimulating Industry Development

    Chapter 3 Recombinant Human Granulocyte Colony-StimulatingIndustry Chain Analysis

    • 3.1 Recombinant Human Granulocyte Colony-Stimulating Industry Chain

    • 3.2 Recombinant Human Granulocyte Colony-Stimulating Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Recombinant Human Granulocyte Colony-Stimulating Market

    • 3.3 Recombinant Human Granulocyte Colony-Stimulating Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Recombinant Human Granulocyte Colony-Stimulating Market

    Chapter 4 China Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 4.1 China Recombinant Human Granulocyte Colony-Stimulating Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Recombinant Human Granulocyte Colony-Stimulating Total Production Volume and Growth Rate from Production Side

    • 4.5 China Recombinant Human Granulocyte Colony-Stimulating Production Volume and Growth Rate, by Type

      • 4.5.1 China Recombinant Human Granulocyte Colony-Stimulating Production Volume and Growth Rate of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

      • 4.5.2 China Recombinant Human Granulocyte Colony-Stimulating Production Volume and Growth Rate of Lenograstim (Granocyte)

      • 4.5.3 China Recombinant Human Granulocyte Colony-Stimulating Production Volume and Growth Rate of Others

    Chapter 5 China Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Recombinant Human Granulocyte Colony-Stimulating Total Market Size and Growth Rate from Consumption End

    • 5.5 China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate, by Application

      • 5.5.1 China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Chemotherapy Induced Neutropenia

      • 5.5.2 China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Stem Cell Transplants

      • 5.5.3 China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Before Blood Donation

      • 5.5.4 China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Others

    Chapter 6 China Recombinant Human Granulocyte Colony-Stimulating Market, by Region

    • 6.1 China Recombinant Human Granulocyte Colony-Stimulating Production Volume and Production Value, by Region

    • 6.2 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Sales Value, by Region

    Chapter 7 North China Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 7.1 North China Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 7.2 North China Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    Chapter 8 Central China Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 8.1 Central China Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 8.2 Central China Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    Chapter 9 South China Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 9.1 South China Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 9.2 South China Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    Chapter 10 East China Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 10.1 East China Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 10.2 East China Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    Chapter 11 Northeast China Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 11.1 Northeast China Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 11.2 Northeast China Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    Chapter 12 Southwest China Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 12.1 Southwest China Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 12.2 Southwest China Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    Chapter 13 Northwest China Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 13.1 Northwest China Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 13.2 Northwest China Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Huaxin

        • 14.1.1 Huaxin Company Profile

        • 14.1.2 Huaxin Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Shijiazhuang Pharmaceutical

        • 14.2.1 Shijiazhuang Pharmaceutical Company Profile

        • 14.2.2 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Qilu Pharmaceutical

        • 14.3.1 Qilu Pharmaceutical Company Profile

        • 14.3.2 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Zhaoke

        • 14.4.1 Zhaoke Company Profile

        • 14.4.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Amoytop Biotech

        • 14.5.1 Amoytop Biotech Company Profile

        • 14.5.2 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Triprime

        • 14.6.1 Triprime Company Profile

        • 14.6.2 Triprime Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Amgen

        • 14.7.1 Amgen Company Profile

        • 14.7.2 Amgen Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Sinovac

        • 14.8.1 Sinovac Company Profile

        • 14.8.2 Sinovac Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Kawin

        • 14.9.1 Kawin Company Profile

        • 14.9.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Gensci

        • 14.10.1 Gensci Company Profile

        • 14.10.2 Gensci Recombinant Human Granulocyte Colony-Stimulating Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Recombinant Human Granulocyte Colony-Stimulating Industry Research Conclusions

    • 15.2 Recombinant Human Granulocyte Colony-Stimulating Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Industry Market Size (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production Volume, Production Value and Growth Rate of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production Volume, Production Value and Growth Rate of Lenograstim (Granocyte) (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate of Chemotherapy Induced Neutropenia (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate of Stem Cell Transplants (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate of Before Blood Donation (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

    • Figure Central China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

    • Figure South China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

    • Figure East China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2018-2029

    • Figure Recombinant Human Granulocyte Colony-Stimulating Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2018

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2023

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production Volume and Growth Rate of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production Volume and Growth Rate of Lenograstim (Granocyte) (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2018

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2023

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Total Market Size and Growth Rate from Consumption End

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Chemotherapy Induced Neutropenia (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Stem Cell Transplants (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Before Blood Donation (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Others (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Production Volume by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Region (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Production Value by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Production Value Share by Region (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production Value Share by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Volume by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Region (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Value by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Value Share by Region (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Value Share by Region (2018-2023)

    • Table North China Recombinant Human Granulocyte Colony-Stimulating Production Volume by Type (2018-2023)

    • Table North China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Figure North China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Table North China Recombinant Human Granulocyte Colony-Stimulating Sales Volume by Application (2018-2023)

    • Table North China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Figure North China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Table Central China Recombinant Human Granulocyte Colony-Stimulating Production Volume by Type (2018-2023)

    • Table Central China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Figure Central China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Table Central China Recombinant Human Granulocyte Colony-Stimulating Sales Volume by Application (2018-2023)

    • Table Central China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Figure Central China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Table South China Recombinant Human Granulocyte Colony-Stimulating Production Volume by Type (2018-2023)

    • Table South China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Figure South China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Table South China Recombinant Human Granulocyte Colony-Stimulating Sales Volume by Application (2018-2023)

    • Table South China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Figure South China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Table East China Recombinant Human Granulocyte Colony-Stimulating Production Volume by Type (2018-2023)

    • Table East China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Figure East China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Table East China Recombinant Human Granulocyte Colony-Stimulating Sales Volume by Application (2018-2023)

    • Table East China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Figure East China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Table Northeast China Recombinant Human Granulocyte Colony-Stimulating Production Volume by Type (2018-2023)

    • Table Northeast China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Figure Northeast China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Table Northeast China Recombinant Human Granulocyte Colony-Stimulating Sales Volume by Application (2018-2023)

    • Table Northeast China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Table Southwest China Recombinant Human Granulocyte Colony-Stimulating Production Volume by Type (2018-2023)

    • Table Southwest China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Figure Southwest China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Table Southwest China Recombinant Human Granulocyte Colony-Stimulating Sales Volume by Application (2018-2023)

    • Table Southwest China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Table Northwest China Recombinant Human Granulocyte Colony-Stimulating Production Volume by Type (2018-2023)

    • Table Northwest China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Figure Northwest China Recombinant Human Granulocyte Colony-Stimulating Production Volume Share by Type (2018-2023)

    • Table Northwest China Recombinant Human Granulocyte Colony-Stimulating Sales Volume by Application (2018-2023)

    • Table Northwest China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share by Application (2018-2023)

    • Table Huaxin Company Profile

    • Table Huaxin Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)

    • Table Shijiazhuang Pharmaceutical Company Profile

    • Table Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)

    • Table Qilu Pharmaceutical Company Profile

    • Table Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)

    • Table Zhaoke Company Profile

    • Table Zhaoke Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)

    • Table Amoytop Biotech Company Profile

    • Table Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)

    • Table Triprime Company Profile

    • Table Triprime Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)

    • Table Sinovac Company Profile

    • Table Sinovac Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)

    • Table Kawin Company Profile

    • Table Kawin Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)

    • Table Gensci Company Profile

    • Table Gensci Recombinant Human Granulocyte Colony-Stimulating Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US